Fellowship

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Search
Generic filters
Search
Generic filters

Name

Position

Level

Elected

State

Principal Director
The George Institute for Global Health
Fellow
2016
NSW

Professor Robyn Norton is the founding Principal Director of one of the most successful medical research institutes in Australia, The George Institute for Global Health. Established in 1999 with 3 permanent staff, the Institute now includes over 500 individuals, headquartered in Sydney, with additional centres in China, India and the United Kingdom. Professor Norton is a globally recognised leader in injury research, which includes initiating and leading the first of a number of high impact trials conducted in the field of critical care. Her pioneering work on injury prevention in low and middle income countries is globally recognised.

Director of Serology, Virology and OTDS screening (SAViD). Chair Biosecurity Quality Assurance Program QAP
SEALS Department of Microbiology, NSW Health Pathology
Fellow
2016
NSW

William Rawlinson is a clinician scientist recognised internationally for translational research into cytomegalovirus, congenital malformation from infections, and viral diseases of immunosuppressed patients.  He established, and oversees, serology and virology clinical research programs, state-wide transplant donor screening, and national quality programs for serology and biosecurity.  He is conjoint professor at UNSW while holding an NHMRC Practitioner Fellowship.  His research has attracted $41 million in competitive funding and his 290 publications have an H-index of 52.  His contributions are recognised by an Order of Australia (AM) for services to medical sciences, Fenner prize, and the Australian Council on Healthcare Standards Gold medal.

Director and CEO
QIMR Berghofer Medical Research Institute
Fellow
2016
QLD

Professor Fabienne Mackay is an internationally renowned immunologist who has published over 138 highly cited research articles and reviews. Her h-index is 56 (12,396 citations). In 2012, she was awarded the Thomson Reuters Citation and innovation Award, and in 2014 a Trophy from the French ministry of foreign affairs for outstanding achievement in research and education as an expatriate. One of her many contributions has been the discovery of BAFF/BLyS as a key factor driving lupus, a breakthrough discovery which led to the development of a now FDA-approved BAFF inhibitor: the first new treatment for lupus in over 50 years.

AC FAA FASSA FAHMS
Scientia Professor/NHMRC Senior Principal Research Fellow
The University of New South Wales
Fellow
2016
NSW

Richard Bryant is an internationally renowned authority in the field of mental health following traumatic events. Amongst his many world‐first achievements, Bryant’s development of assessment tools for identifying recently traumatized people who may subsequently develop PTSD has become the international gold standard in the field. Moreover, he was subsequently tasked with overseeing the new diagnostic guidelines for ‘acute stress disorder’ in the 2013 edition of the American Psychiatric Association’s diagnostic system (DSM‐5).  His outstanding profile is evidenced by prestigious research fellowships, senior executive roles in international professional organisations and Fellowship of the ASSA. He would be an influential Academy member.

Consultant Paediatrician
Children’s Health Queensland Hospital and Health Service
Fellow
2016
QLD

Professor Claire wainwright is the Head of Cystic Fibrosis (CF) services which provide state-wide services for around 420 children with CF across Queensland.  She also runs the respiratory service for the only national clinic caring for children with ataxia telangiectasia.  She has a long standing research interest in airway diseases, including bronchiolitis, asthma, cystic fibrosis and rare lung diseases.  Professor Wainwright conducted the first randomized trial of BAL-directed therapy to improve clinical outcomes in infants and young children with CF.  She has also been instrumental in the design and conduct of clinical trials that have brought ivacaftor and lumacaftor to the CF community.

Research Professor
Griffith University
Fellow
2016
QLD

Professor Cripps has made significant contributions to the delivery of health services, leadership in health academia and in research. He has led and implemented programs for the training of thousands of future of health professionals. His research has focused on the study of mucosal immunology and preventing respiratory infections. Professor Cripps’ efforts have brought together academics, researchers and clinicians, to ensure that research is relevant to global health issues, informed by the needs of the community and focused on translation into practice. In 2015 he was made an officer of the Order of Australia for his distinguished service to health.

AM FRS FAA FAHMS
Deputy Director and Head, Developmental and Stem Cell Biology Division
Victor Chang Cardiac Research Institute
Fellow
2016
NSW

Richard Harvey is a pioneer of the molecular era of heart development and congenital heart disease (CHD) research, and has contributed significantly to cardiac regeneration biology.  His discovery of the homeodomain transcription factor Nkx2‐5 provided the key entry point for molecular dissection of heart development and CHD in humans.  His work defined new patterning principals that govern heart development and the many layers of regulation in heart formation and disease.  His studies have redefined our vision of the developing heart and opened the doors to systems level analysis, and cardiac bioengineering and stem cell biology.

AO FAA FTSE FAHMS
Senior Deputy Director; Laureate Professor
The Florey Institute of Neuroscience and Mental Health
Fellow
2015
VIC

Colin Masters’ work over the last 35 years is widely acknowledged as having had a major influence on Alzheimer’s disease research world-wide, particularly the collaborative studies conducted with Konrad Beyreuther in which they discovered the proteolytic neuronal origin of the Aβ amyloid protein which causes Alzheimer’s disease. Masters has continued to identify and develop effective rational therapeutic and diagnostic strategies for disease modification, perhaps even prevention. Masters’ publishes on average 30 papers a year, serves on 19 Editorial Boards, is an advisory member of 17 research organizations and continues to lecture widely, both nationally and internationally.

Executive Director
Children’s Cancer Institute
Fellow
2015
NSW

Professor Michelle Haber is a world leader in the field of childhood cancer research. She has made fundamental discoveries in the area of drug resistance in neuroblastoma which have had major impact on the global research community. She has translated these discoveries into new therapeutics that are currently being clinically tested and has developed into a key leader of the Australian biomedical research community.

Co Leader, Hematological Malignancies Program
St Jude Children’s Research Hospital, South Australian Health and Medical Research Institute
Fellow
2015
International

Charles Mullighan is an academic haematologist who has devoted his research career to defining the genetic basis of acute lymphoblastic leukaemia, a leading cause of childhood cancer death. His work has resulted in multiple seminal studies that have transformed our understanding of this disease and related tumours. He is regarded as an international leader in this research and has major leadership positions in the hematology community. His work has had major clinical impact by identifying new genetic markers that assist diagnosis and prediction of prognosis, and by identifying new targets for intervention with targeted
therapies in high risk leukaemia.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants. 

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community
      •  

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the Secretariat for application forms and further instructions on how to submit the completed nomination documentation. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the Secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2021
Newly elected Fellows of 2021 are inducted at the AGM/Scientific Meeting.

October 2021-November 2021
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2021
Nominations allocated to Selection Committees.

January – April 2022
Referees’ reports sought.

Early May 2022
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-Mid-July 2022
Council meets to finalise recommendations.

Late July 2022
Full Fellowship invited to comment on recommended new fellows.

Early August 2022
Newly elected Fellows are informed of their successful appointment.

October 2022
Newly elected Fellows of 2022 inducted at the AGM/Scientific Meeting.

Find out more

Whether you’re looking to nominate a colleague for an award, make a donation to the Academy or simply find out more about the work we do, research we advance and health policy advice we provide, sign up to our mailing list today.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.